Navigation Links
Derma Sciences to Enter Phase II Development of Wound Healing Product That May Use Body's Own Naturally Occurring Stem Cells
Date:1/24/2008

" "intend," "could," "estimate" or "continue" are intended to identify forward-looking statements. Readers are cautioned, that certain important factors may affect the Company's actual results and could cause such results to differ materially from any forward-looking statements which may be made in this release or which are otherwise made by or on behalf of the Company. Factors which may affect the Company's results include, but are not limited to, product demand, market acceptance, impact of competitive products and prices, product development, completion of an acquisition, commercialization or technological difficulties, the success or failure of negotiations and trade, legal, social and economic risks. Additional factors that could cause or contribute to differences between the Company's actual results and forward-looking statements Include but are not limited to, those discussed in the Company's filings with the Securities and Exchange Commission.

Contact: Derma Sciences Inc Allen & Caron Inc

Edward J. Quilty Rudy Barrio (US Investors)

Chairman and CEO r.barrio@allencaron.com

equilty@dermasciences.com

(609) 514-4744 Brian Kennedy (media)

brian@allencaron.com

(212) 691-8087


'/>"/>
SOURCE Derma Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
2. Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)
3. Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome
4. Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinsons Disease
5. NicOx and Ferrer Present Promising Clinical and Preclinical Results in Dermatology
6. Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting
7. Phosphagenics to Conduct a Phase 1 Transdermal Oxycodone Clinical Trial
8. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences Claims
11. Human Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...29 Stimulated by the ten years of ...Medical Systems USA announced today, at the Radiol...ing, the formation of its Medical Informatics Div...new group will integrate all functions associated ...s a platform for future growth. ,, Several orga...
(Date:11/29/2009)...29 Researchers using functional ma...ivation have found that men and women respond diff...g to a study presented today at the annual meeting...A). ,, "Men may direct more attention to sensor... them in terms of implications for required action...
(Date:11/27/2009)...option to prevent illnesses caused by subtypes A a...ov. 27 The U.S. Food an...eople ages 18 years and older to prevent disease c... (Logo: http://www.newscom.com/cgi-bin/prnh/20090...tis Vaccines and Diagnostics in Siena, Italy, was ...
Breaking Medicine Technology:FUJIFILM Establishes Medical Informatics Organization 2FUJIFILM Establishes Medical Informatics Organization 3New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3FDA Approves Agriflu Seasonal Influenza Vaccine 2Hungarian Cancer Formula Producer Questions U S Introduction of AveUltra 14874 1Hungarian Cancer Formula Producer Questions U S Introduction of AveUltra 14874 2bioMerieux and GSK Sign Theranostics Agreement to Develop Predictive Test for Selecting Breast Cancer Treatment 6338 1bioMerieux and GSK Sign Theranostics Agreement to Develop Predictive Test for Selecting Breast Cancer Treatment 6338 2bioMerieux and GSK Sign Theranostics Agreement to Develop Predictive Test for Selecting Breast Cancer Treatment 6338 3Mirixa Australia Achieves Six Month Milestones 6335 1Mirixa Australia Achieves Six Month Milestones 6335 2Mirixa Australia Achieves Six Month Milestones 6335 3
...USINESS WIRE)--Jul 3, 2007 - EPIX,Pharmaceuticals,....,Kauffman, M.D., Ph.D., chief executive officer o...erg, Towbin Emerging Growth,Opportunities Conferen... the Mandarin Oriental Hotel in New York, NY., The...ssed on the,EPIX website, www.epixpharma.com, in t...
...ESS WIRE)--Jul 3, 2007 - Inspire,Pharmaceuticals, ...,Shaffer, Ph.D., President and CEO, will present a...tunities Conference on,Wednesday, July 11, 2007 at... presentation will be available on Inspire,s,web s...f the,webcast presentation will also be available ...
Other Medicine Technology:EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin,Emerging Growth Opportunities Conference 2
(Date:11/29/2009)... DETROIT Using mannequins to teach doctors-in-tra... effective way to improve their skills without com...new study from Henry Ford Hospital. , The study ...an be a valuable tool to improve medical residents...ng some of the more common ultrasound-guided proce...
(Date:11/29/2009)... doctors unaware the sleep disorder boosts urine p... 29 (HealthDay News) -- People who wake up during ... a urological problem. Sleep apnea, a breathing-re...ew study suggests that nighttime urination, or noc...or obstructive sleep apnea, a disorder in which so...
(Date:11/28/2009)...at offenders were more likely to consider change a...nds , , FRIDAY, Nov. 27 (HealthDay News)...o consider why they should stop their dangerous be...anges, researchers have found. , The new study ...g-while-impaired convictions, who were randomly as...
(Date:11/27/2009)... Biotech firm Replikins Ltd. ...e H1N1 virus genomic data. It shows that the leth...7 (s.d. 4.5) during the virus,s current outbreak i...s this week of 2.0 (s.d. 0.1). The H1N1 infectivit... Boston (PRWEB) November 27, 2009 -- ...
(Date:11/27/2009)... , KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewswire...q: SHMR ) ( "Shamir" ), a leading provider of inn...lens market, announced today that its board of dir...aggregate amount of US$ 10 million (approximately ...epresentative rate of exchange), or approximately ...
Breaking Medicine News(10 mins):Health News:Simulated training for ultrasound-guided procedures improves safety without risk to patients 2Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3
...gly viewing cured meats with caution. One reason i...Pulmonary Disease or COPD. According to a rece... as a preservative and color fixative) could well ... University Medical Center in New York City examin...
... about improving HIV detection and treatment; unfo... Children are at the wrong end of the stick, a new...ind out the challenges to HIV care for children in...iation with the Social Awareness Services Organiza...
... and reduces relapse rates in multiple sclerosis (...atients with relapsing MS. //Vision loss is one of...The findings are published in the April 17, 2007, ...EL studies, which involved 2,138 men and women wit...
...ong indigenous people is not due to their genetic .../ . The study was authored by Dr Yin Paradie...of Health Research along with two researchers from...genetic pre-disposition specific to indigenous pop...
... at the evolution of causal organisms of hithert...arn is the result of overzealous use of antibiotic...nt by the U.S Centers For Disease Control (CDC) th...ting worry lines on many a health expert. Sa...
...edictor for liver cancer, says a US study. Usi...iomarker,// researchers at Columbia University's M...eans for early detection of liver cancer, says the... been associated with the development of liver car...
Other Medicine News:Health News:Hotdogs And Co.-The Long And Short Of It 2Health News:MS Drug Helps Reduce Vision Loss 2Health News:Blood DNA Predicts Liver Cancer Early 2
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...
Medicine Products: